| Literature DB >> 35049683 |
Young-Jen Lin1, Te-Wei Ho1, Chien-Hui Wu1, Ting-Chun Kuo1, Ching-Yao Yang1, Jin-Ming Wu1,2, Yu-Wen Tien2.
Abstract
We retrospectively collected PD patients with a performance of bile culture between 2007 and 2019 in our institute. As to bile culture, we used a swab to do intraoperative bile cultures after transection of the CBD. IAA was defined as the documental bacteriological culture from either a turbid discharge from the intraoperatively placed drain in patients with a clinical picture consistent with infection or a postoperative fluid collection managed by CT-guided placement of drains. A total of 1244 PD patients were identified, and 539 (43.3%) subjects with bile sampling were included for analysis. Among these study patients, 433 (80.3%) developed bile contamination (positive bile culture). Bile contamination showed a significantly higher rate of IAA compared to non-bile contamination (17.1% vs. 0.9%, p < 0.001). The rate of co-shared microorganisms in both bile and abscess was 64.1%. On the multivariate analysis, age and specific bile microorganisms (Enterococcus species, Escherichia Coli, Streptococcus species, Citrobacter species, and Candida) are significantly associated with development of IAA. Specific bile microorganisms are the highly significant factors associated with development of IAA. The strategy to prevent bile spillage during PD should be considered to minimize afterward contamination of the abdominal cavity and prevent IAA.Entities:
Keywords: biliary drainage; intra-abdominal abscess; pancreaticoduodenectomy; positive bile culture; surgical complication
Mesh:
Year: 2021 PMID: 35049683 PMCID: PMC8774444 DOI: 10.3390/curroncol29010009
Source DB: PubMed Journal: Curr Oncol ISSN: 1198-0052 Impact factor: 3.677
Comparison of the study subjects between with and without bile contamination.
| Variable | Bile Contamination ( | ||
|---|---|---|---|
| Clinical Variable | No ( | Yes ( | |
| Age, y, median (IQR) | 60.8 (52.5–70.2) | 66.4 (57.1–74.0) | 0.006 |
| Gender | 0.630 | ||
| Female | 46 (43.4%) | 199 (46.0%) | |
| Male | 60 (56.6%) | 234 (54.0%) | |
| BMI, median (IQR) | 22.2 (20.4–24.6) | 22.5 (20.7–24.6) | 0.630 |
| Charlson comorbidity index score | 0.063 | ||
| ≤2 | 27 (25.5%) | 76 (17.6%) | |
| >2 | 79 (74.5%) | 357 (82.4%) | |
| ASA physical status | 0.720 | ||
| <3 | 35 (33.0%) | 151 (34.9%) | |
| ≥3 | 71 (67.0%) | 282 (65.1%) | |
| Pancreatitis history | 15 (14.2%) | 51 (11.8%) | 0.500 |
| Pathology | 0.960 | ||
| Periampullary cancer | 68 (64.2%) | 279 (64.4%) | |
| Non periampullary cancer | |||
| Benign or low malignant neoplasm * | 27 (25.5%) | 100 (23.1%) | |
| Chronic pancreatitis | 10 (9.4%) | 50 (11.6%) | |
| Neuroendocrine tumor | 1 (0.9%) | 4 (0.9%) | |
| Preoperative T-BIL level (mg/dL, median, range) | |||
| T-BIL Maximum at any time | 0.9 (0.6–5.8) | 2.6 (1.0–9.8) | <0.001 |
| T-BIL, Maximum within 2 day before surgery | 0.9 (0.6–3.2) | 1.4 (0.9–2.9) | 0.001 |
| Preoperative usage of antibiotics within 30 days | 53 (50.0%) | 303 (70.0%) | <0.001 |
| Preoperative biliary drainage | 21 (19.8%) | 181 (41.8%) | <0.001 |
| Percutaneous transhepatic cholangiography & drainage | 18 (17.0%) | 39 (9.0%) | 0.061 |
| Endoscopic retrograde biliary drainage | 3 (2.8%) | 142 (32.8%) | <0.001 |
| Operation time, min, median (IQR) | 223.5 (194.0–268.0) | 260.0 (225.0–310.0) | <0.001 |
| Intraabdominal abscess | 1 (0.9%) | 74 (17.1%) | <0.001 |
| Superficial surgical site infection | 4 (3.8%) | 14 (3.2%) | 0.780 |
| Clinically relevant POPF | 28 (26.4%) | 110 (25.4%) | 0.610 |
BMI, Body Mass Index; ASA physical status, American Society of Anesthesiologists physical status; T-BIL, Total bilirubin; POPF postoperative pancreatic fistula. * Mucinous or serous cystadenoma, intraductal papillary mucinous neoplasm, solid pseudopapillary epithelial neoplasm.
Figure 1Comparison of microorganisms grown in intraoperative bile cultures between different PBD.
Figure 2Comparison of microorganisms grown in intraoperative bile cultures and intra-abdominal abscess cultures.
Statistical analysis of microorganisms to predict intra-abdominal abscess.
| Microorganisms | Odds Ratio | 95% CI | |
|---|---|---|---|
| Enterococcus species | 4.156 | 2.661–6.491 | <0.001 |
| Enterobacter species | 2.515 | 1.546–4.093 | <0.001 |
| Escherichia Coli | 2.333 | 1.384–3.933 | 0.001 |
| Klebsiella species | 1.195 | 0.697–2.048 | 0.517 |
| Streptococcus species | 2.796 | 1.502–5.206 | 0.001 |
| Citrobacter species | 3.376 | 1.686–6.762 | 0.001 |
| Pseudomonas Aeruginosa | 1.783 | 0.889–3.581 | 0.104 |
| Aeromonas species | 2.094 | 1.002–4.376 | 0.057 |
| Clostridium species | 0.728 | 0.316–1.676 | 0.455 |
| Proteus species | 1.099 | 0.469–2.573 | 0.827 |
| Candida species | 4.994 | 1.837–13.572 | 0.002 |
Univariate analysis and adjusted multivariate analysis to predict intra-abdominal abscess.
| Clinical Variant | Univariate | Multivariate | ||
|---|---|---|---|---|
| Odds Ratio | 95% CI | |||
| Age | <0.001 | 1.023 | 1.004–1.041 | 0.014 |
| Male | 0.580 | 1.151 | 0.769–1.724 | 0.493 |
| ASA ≥ 3 | 0.990 | 0.862 | 0.544–1.366 | 0.529 |
| BMI | 0.240 | 1.005 | 0.946–1.067 | 0.867 |
| T-BIL, Maximum within 2 days before surgery | 0.140 | 0.969 | 0.905–1.039 | 0.386 |
| Antibiotic use within 30 days before surgery | 0.170 | 0.930 | 0.598–1.447 | 0.750 |
| Preoperative biliary drainage | 0.010 | |||
| Percutaneous transhepatic cholangiography and drainage (ref: no PBD) | 0.869 | 1.001 | 0.461–2.171 | 0.997 |
| Endoscopic retrograde biliary drainage (ref: no PBD) | <0.001 | 1.176 | 0.676–2.047 | 0.565 |
| CCI score > 2 | 0.105 | 1.610 | 0.812–3.193 | 0.172 |
| Periampullary cancer | 0.020 | 1.041 | 0.626–1.731 | 0.876 |
| Pancreatitis | 0.510 | 1.067 | 0.553–2.056 | 0.846 |
| Clinically relevant postoperative pancreatic fistula | 0.610 | 0.882 | 0.591–1.316 | 0.539 |
| Microorganism | ||||
| Candida species | 0.002 | 4.666 | 1.677–12.981 | 0.003 |
| Enterococcus species | < 0.001 | 4.103 | 2.609–6.454 | <0.001 |
| Citrobacter species | 0.001 | 3.050 | 1.510–6.159 | 0.002 |
| Enterobacter species | <0.001 | 2.231 | 1.349–3.689 | 0.002 |
| Streptococcus species | 0.001 | 2.519 | 1.331–4.767 | 0.005 |
| Escherichia Coli | 0.001 | 2.215 | 1.336–3.671 | 0.002 |
BMI, Body Mass Index; ASA physical status, American Society of Anesthesiologists physical status; T-BIL, Total-bilirubin; CCI score, Charlson comorbidity index score, POPF postoperative pancreatic fistula.
Figure 3Potential mechanism of intra-abdominal abscess.